Amundi’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,471
Closed -$106K 1898
2022
Q3
$106K Hold
7,471
﹤0.01% 1543
2022
Q2
$86K Buy
+7,471
New +$86K ﹤0.01% 1469